Pharma Marketing News Vol. 10, No. 17: 10 November 2011
Welcome to Volume 10, Issue #17 (10 NOVEMBER 2011) of Pharma Marketing News.
Your Wife, Your Choice – Diapers or Detrol (now Toviaz)?
Pfizer's @pfizer_news Twitter account just posted this tweet:
"Toviaz top-line primary endpoint results positive in overactive bladder study of nocturnal urinary urgency http://t.co/OU60l6oZ" (see here).
The...
Pharma Turns Up the Heat on Off-Label “Free Speech” Chilled by FDA – Implications...
"FDA’s regulations censor manufacturers," says the Medical Information Working Group (MIWG), an "informal" group of pharmaceutical companies that includes Allergan, Amgen, Boehringer Ingelheim USA,...
Do Women Take More Drugs Than Men Because They Need To or Because They...
Aside from Viagra, there's hardly a prescription drug I've heard of that women are NOT the major users of. Take, for example, this bit...
Potential for Bias in Commercially Supported CME
Please take 2 minutes to answer a few short questions relating to potential bias in continuing medical education (CME) programs supported by pharma/medical device companies and how to limit the need for industry funding of CME.
FDA Moves the Cheese on Drug Approval Numbers
The FDA and the pharmaceutical industry are bragging about the number of "new" drugs approved in "fiscal year" 2011 (October 1, 2010 through September...
Chantix May Be More Dangerous Than Smoking!
Reuters reports (here) that Chantix is "eight times more likely to be linked with a reported case of suicidal behavior or depression than other...
Google to Shutter Sidewiki on December 5, A Day That Will Live Famously!
Yesterday, Google sent out an email (see here) informing users of its sidewiki service that it will close the service on December 5. Sidewiki...
Are Pharma Reps Important to Docs or Not?
Back in March, 2011, I reviewed a PhRMA sponsored survey of physicians the results of which PhRMA claimed shows that "nearly eight out of...
Lipitor Won’t Go Gentle Into that Good Generic Night
Today's Wall Street Journal reports that "Pfizer Inc. isn't rolling over and conceding the market for its cholesterol-lowering drug Lipitor after the blockbuster brand...
